IQVIA Holdings Inc. (IQV) Stock

NYSE: IQVProvider of advanced analytics, technology solutions, and research services to the life sciences industry.

IQVIA stock price chart

IQV interactive chart →

IQV stock quote & key statistics

IQVIA earnings per share

Income →
Earnings per share

IQVIA revenue & net income

Income →
RevenueNet income

IQVIA annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$16.31B$1.36B$11.93
FY2024$15.40B$1.37B$11.14
FY2023$14.98B$1.36B$10.21
FY2022$14.41B$1.09B$10.17
FY2021$13.87B$966.0M$9.03

Fiscal year ending December 31. Source: company filings via EODHD.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. specializes in providing advanced analytics, technology solutions, and comprehensive clinical research services tailored for the life sciences industry globally. Operating across the Americas, Europe, Africa, and the Asia-Pacific, the company is organized into three key segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

The Technology & Analytics Solutions segment offers a suite of cloud-based applications and associated implementation services. These solutions empower life sciences and healthcare providers to generate and utilize real-world evidence, facilitating informed healthcare decisions and enhancing patient outcomes. Additionally, the segment provides strategic consulting services encompassing advanced analytics and outsourcing of commercial processes, alongside comprehensive country-level performance metrics across pharmaceutical sales channels.

The Research & Development Solutions segment delivers a spectrum of services including project management, clinical monitoring, virtual trials, and strategic planning. It also offers specialized laboratory services such as central laboratory, genomic, bioanalytical, and vaccine and biomarker laboratory services. These capabilities support pharmaceutical, biotechnology, and consumer health companies in advancing clinical trials and drug development initiatives.

The Contract Sales & Medical Solutions segment focuses on healthcare provider and patient engagement services, coupled with scientific strategy and medical affairs support. Catering to pharmaceutical, biotechnology, device, and diagnostic companies, IQVIA plays a pivotal role in optimizing healthcare delivery and enhancing operational efficiencies across the life sciences sector. Founded in 1982 and headquartered in Durham, North Carolina, IQVIA Holdings Inc. continues to innovate and collaborate through strategic partnerships, such as its collaboration with HealthCore, Inc., to drive advancements in healthcare research and technology solutions.

IQVIA stock FAQ

What is the IQVIA stock ticker symbol?

IQVIA Holdings Inc. trades on the NYSE under the ticker symbol IQV.

What sector and industry is IQVIA in?

IQVIA Holdings Inc. is classified in the Healthcare sector, Diagnostics & Research industry.

How many employees does IQVIA have?

IQVIA Holdings Inc. has about 94,000 full-time employees.

What were IQVIA's revenue and earnings last fiscal year?

IQVIA reported revenue of $16.31B and net income of $1.36B in fiscal 2025, with earnings per share of $11.93. Revenue grew 5.9% from the prior year.

Is IQVIA in the S&P 500?

Yes. IQVIA Holdings Inc. (IQV) is a component of the S&P 500, the index of 500 leading U.S. companies widely used as a benchmark for the U.S. stock market.

Is IQVIA in the Russell 1000?

Yes. IQVIA Holdings Inc. (IQV) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.

When did IQVIA go public?

IQVIA stock began trading on May 9, 2013.

S&P 500 Healthcare stocks

All S&P 500 →